The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...
In the medical device industry, FDA inspections are not a regulatory hurdle — they are a powerful tool for improving product ...
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
Fentanyl presents America with a terrible dilemma. More than 74,000 Americans died in 2023 after taking fentanyl or other ...
Ongoing firings at the Department of Health and Human Services and its subagencies will likely impact a sweeping number of agency functions ranging from pandemic preparedness to food and drug ...